id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-325241-paztcjm2	Triki, Haitham	Surgical resection for liver cancer during the COVID-19 outbreak	2020-05-20		.txt	text/plain	1035	62	46	During the 2019 novel coronavirus disease (COVID-19) outbreak, therapeutic strategies must be adapted for liver cancer patients balancing the benefit of surgical resection against the risk of contamination incurred by the patient. In addition, it has been found that lung injury (a common complication of COVID-19) is an independent risk factor for major morbidity and mortality after hepatectomy [5] . Hence, liver resections, especially major or complex hepatectomies, in COVID-19 patients could further deteriorate lung damage and complicate its management. Due to the risk of contamination by SARS-COV-2 before, during or after hospitalization, we believe that liver surgery for cancer should be postponed for patients at high risk of postoperative complications and severe COVID-19, including elderly patient with comorbidities and chronic liver disease. Therapeutic strategies must be adapted to this pandemic, balancing the benefit of liver cancer resection against the risk incurred by the patient during the COVID-19 outbreak.	./cache/cord-325241-paztcjm2.txt	./txt/cord-325241-paztcjm2.txt